FDA decision: Anitocabtagene Autoleucel (anito-cel) by Gilead Sciences (in 2026)
FDA decision on Anitocabtagene Autoleucel (anito-cel) in 2026Economics
FDA decision: Anitocabtagene Autoleucel (anito-cel) by Gilead Sciences (in 2026)
FDA decision on Anitocabtagene Autoleucel (anito-cel) in 2026Economics
Kalshi 活跃 1 个市场 互斥·78¢ What will the FDA's decision be on Anitocabtagene Autoleucel (anito-cel) by Gilead Sciences in 2026?·$0 总交易量·-- 流动性·-- OI
5mo·Jan 8, 2027
追踪你的预测市场持仓
连接你的 Kalshi 账户，追踪你的合约、盈亏和结算。
What will the FDA's decision be on Anitocabtagene Autoleucel (anito-cel) by Gilead Sciences in 2026?+0.0% 24h
Yes 78%
No 22%
$0 量
暂无图表数据
If the FDA's decision on Anitocabtagene Autoleucel (anito-cel) by Gilead Sciences in 2026 is a full approval or an accelerated approval, the market resolves to Yes.
追踪您在 Kalshi 上的投注——以及一切其他资产
从您的 Kalshi 头寸、盈亏和实时赔率开始，创建免费投资组合。然后添加加密钱包、交易所、DeFi 等——一切尽在一处。
Polymarket
Kalshi
50+ Chains
40+ Exchanges
DeFi
NFTs
16K+ Tokens
100% 免费· 只读· 加密保护